ESC 365 - Biomarker role of relaxins in myocardial fibrosis and left ventricular diastolic function in ischemic heart failure with reduced ejection fraction

HFA Premium Access

Biomarker role of relaxins in myocardial fibrosis and left ventricular diastolic function in ischemic heart failure with reduced ejection fraction

Session: Poster Session 3 - Chronic Heart Failure – Diagnostic Methods

Topic: Biomarkers

Speaker: Doctor E. Gara (Budapest, HU)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Doctor Edit Gara

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

0 follower

23 more presentations in this session

Lung ultrasound in the diagnosis of cardiogenic dyspnea

Speaker: Doctor T. Valova (Sofia, BG)

Changes in circulating miRNAs as a prognostic tool for heart failure related morbidity and mortality in patients suffering from stable HFpEF: A subgroup analysis of the ALDO-DHF trial

Speaker: Mr J. Petutschnigg (Berlin, DE)

Eyes on amyloidosis: Severe microvascular retinal dysfunction in cardiac amyloidosis.

Speaker: Mr E. Zampiccoli (Zuerich, CH)

Derivation and validation of a conversion equation between B-type natriuretic peptide and N-terminal pro BNP levels

Speaker: Mr S. Kasahara (Sendai, JP)

Prevalence of heart failure with preserved and reduced left ventricular ejection fraction and diagnostic value of MR-proANP in 803 outpatients with type 2 diabetes

Speaker: Doctor J. Jensen (Copenhagen, DK)

Access the full session

Poster Session 3 - Chronic Heart Failure – Diagnostic Methods

Speakers: Doctor E. Gara, Doctor T. Valova, Mr J. Petutschnigg, Mr E. Zampiccoli, Mr S. Kasahara...

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources